Research Professor, Epidemiology
Adjunct Research Professor, Urology
EducationPhD Epidemiology, Johns Hopkins University, 1985
MPH Epidemiology, Emory University, 1982
BSN Nursing Rn/bs, Georgia State University, 1980
- Genetic Epidemiology of Prostate Cancer (PROGRESS)
- NSAIDS and Other Medications in Prostate Cancer Etiology
Dr. Stanford's research interests are in chronic disease epidemiology, specifically prostate cancer. She has worked on population-based case-control studies of risk factors (environmental, lifestyle, and genetic) for prostate cancer, studies of risk factors for prostate cancer recurrence/progression/mortality, studies of quality of life and function in prostate cancer survivors, and genetic susceptibility to sporadic and hereditary prostate cancer. Currently, Dr. Stanford is working on several next-generation sequencing projects involving hereditary prostate cancer families with aggressive and/or early onset disease. She is also working on further validation for a panel of genetic markers she and her collaborators have found to be associated with lethal prostate cancer, and she is involved in numerous studies that are genotyping candidate SNPs as well as GWAS for prostate cancer.
Dr. Stanford teaches EPI 591 - Current Literature in Epidemiology during Winter Quarter.
In The News
Researcher Finds Height Plays Role in Aggressive Prostate Cancer Risk
UW School of Public Health News, 09/05/2017
Germline Missense Variants in the BTNL2 Gene Are Associated with Prostate Cancer Susceptibility
Cancer Epi Biomarkers & Prevention, 09/12/2013
Statins Tied to Better Prostate Cancer Outcomes
New York Times Well Blog, 05/06/2013